Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium.

Seano G, Nia HT, Emblem KE, Datta M, Ren J, Krishnan S, Kloepper J, Pinho MC, Ho WW, Ghosh M, Askoxylakis V, Ferraro GB, Riedemann L, Gerstner ER, Batchelor TT, Wen PY, Lin NU, Grodzinsky AJ, Fukumura D, Huang P, Baish JW, Padera TP, Munn LL, Jain RK.

Nat Biomed Eng. 2019 Mar;3(3):230-245. doi: 10.1038/s41551-018-0334-7. Epub 2019 Jan 7.

PMID:
30948807
2.

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer.

Askoxylakis V, Ferraro GB, Badeaux M, Kodack DP, Kirst I, Shankaraiah RC, Wong CSF, Duda DG, Fukumura D, Jain RK.

NPJ Breast Cancer. 2019 Jan 15;5:4. doi: 10.1038/s41523-018-0100-8. eCollection 2019.

3.

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models.

Keklikoglou I, Cianciaruso C, Güç E, Squadrito ML, Spring LM, Tazzyman S, Lambein L, Poissonnier A, Ferraro GB, Baer C, Cassará A, Guichard A, Iruela-Arispe ML, Lewis CE, Coussens LM, Bardia A, Jain RK, Pollard JW, De Palma M.

Nat Cell Biol. 2019 Feb;21(2):190-202. doi: 10.1038/s41556-018-0256-3. Epub 2018 Dec 31.

PMID:
30598531
4.

Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.

Arvanitis CD, Askoxylakis V, Guo Y, Datta M, Kloepper J, Ferraro GB, Bernabeu MO, Fukumura D, McDannold N, Jain RK.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8717-E8726. doi: 10.1073/pnas.1807105115. Epub 2018 Aug 27.

5.

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.

Zhao Y, Liu P, Zhang N, Chen J, Landegger LD, Wu L, Zhao F, Zhao Y, Zhang Y, Zhang J, Fujita T, Stemmer-Rachamimov A, Ferraro GB, Liu H, Muzikansky A, Plotkin SR, Stankovic KM, Jain RK, Xu L.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2077-E2084. doi: 10.1073/pnas.1719966115. Epub 2018 Feb 9.

6.

MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding.

Sanz RL, Ferraro GB, Kacervosky J, Salesse C, Gowing E, Hua L, Rambaldi I, Beaubien F, Holmbeck K, Cloutier JF, Lévesque M, Murai K, Fournier AE.

J Neurosci. 2018 Jan 17;38(3):518-529. doi: 10.1523/JNEUROSCI.0962-17.2017. Epub 2017 Dec 1.

7.

A cerebellar window for intravital imaging of normal and disease states in mice.

Askoxylakis V, Badeaux M, Roberge S, Batista A, Kirkpatrick N, Snuderl M, Amoozgar Z, Seano G, Ferraro GB, Chatterjee S, Xu L, Fukumura D, Duda DG, Jain RK.

Nat Protoc. 2017 Nov;12(11):2251-2262. doi: 10.1038/nprot.2017.101. Epub 2017 Oct 5.

8.

Anti-VEGF treatment improves neurological function in tumors of the nervous system.

Zhang N, Chen J, Ferraro GB, Wu L, Datta M, Jain RK, Plotkin SR, Stemmer-Rachamimov A, Xu L.

Exp Neurol. 2018 Jan;299(Pt B):326-333. doi: 10.1016/j.expneurol.2017.09.008. Epub 2017 Sep 11. Review.

PMID:
28911884
9.

Ectodomain shedding of Limbic System-Associated Membrane Protein (LSAMP) by ADAM Metallopeptidases promotes neurite outgrowth in DRG neurons.

Sanz RL, Ferraro GB, Girouard MP, Fournier AE.

Sci Rep. 2017 Aug 11;7(1):7961. doi: 10.1038/s41598-017-08315-0.

10.

Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors.

Askoxylakis V, Arvanitis CD, Wong CSF, Ferraro GB, Jain RK.

Adv Drug Deliv Rev. 2017 Sep 15;119:159-174. doi: 10.1016/j.addr.2017.06.011. Epub 2017 Jun 22. Review.

PMID:
28648712
11.

Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?

Askoxylakis V, Kodack DP, Ferraro GB, Jain RK.

Breast Cancer Res Treat. 2017 Sep;165(2):467-468. doi: 10.1007/s10549-017-4351-0. Epub 2017 Jun 22. No abstract available.

PMID:
28643019
12.

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Kodack DP, Askoxylakis V, Ferraro GB, Sheng Q, Badeaux M, Goel S, Qi X, Shankaraiah R, Cao ZA, Ramjiawan RR, Bezwada D, Patel B, Song Y, Costa C, Naxerova K, Wong CSF, Kloepper J, Das R, Tam A, Tanboon J, Duda DG, Miller CR, Siegel MB, Anders CK, Sanders M, Estrada MV, Schlegel R, Arteaga CL, Brachtel E, Huang A, Fukumura D, Engelman JA, Jain RK.

Sci Transl Med. 2017 May 24;9(391). pii: eaal4682. doi: 10.1126/scitranslmed.aal4682. Erratum in: Sci Transl Med. 2019 Jan 30;11(477):.

13.

Closing the gap: astrocytes and brain metastasis.

Ferraro GB, Kodack DP, Askoxylakis V, Jain RK.

Cell Res. 2016 Sep;26(9):973-4. doi: 10.1038/cr.2016.96. Epub 2016 Aug 12.

14.

Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.

Askoxylakis V, Ferraro GB, Kodack DP, Badeaux M, Shankaraiah RC, Seano G, Kloepper J, Vardam T, Martin JD, Naxerova K, Bezwada D, Qi X, Selig MK, Brachtel E, Duda DG, Huang P, Fukumura D, Engelman JA, Jain RK.

J Natl Cancer Inst. 2015 Nov 7;108(2). pii: djv313. doi: 10.1093/jnci/djv313. Print 2016 Feb.

15.

Emerging strategies for treating brain metastases from breast cancer.

Kodack DP, Askoxylakis V, Ferraro GB, Fukumura D, Jain RK.

Cancer Cell. 2015 Feb 9;27(2):163-75. doi: 10.1016/j.ccell.2015.01.001. Review.

16.

IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth.

Sanz R, Ferraro GB, Fournier AE.

J Biol Chem. 2015 Feb 13;290(7):4330-42. doi: 10.1074/jbc.M114.628438. Epub 2014 Dec 23.

17.

Neurite outgrowth and growth cone collapse assays to assess neuronal responses to extracellular cues.

Kaplan A, Sanz R, Ferraro GB, Alchini R, Fournier AE.

Methods Mol Biol. 2014;1162:43-56. doi: 10.1007/978-1-4939-0777-9_4.

PMID:
24838957
18.

Rho signaling and axon regeneration.

McKerracher L, Ferraro GB, Fournier AE.

Int Rev Neurobiol. 2012;105:117-40. doi: 10.1016/B978-0-12-398309-1.00007-X. Review.

PMID:
23206598
19.

Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage.

Ferraro GB, Morrison CJ, Overall CM, Strittmatter SM, Fournier AE.

J Biol Chem. 2011 Sep 9;286(36):31418-24. doi: 10.1074/jbc.M111.249169. Epub 2011 Jul 18.

20.

14-3-3 proteins regulate protein kinase a activity to modulate growth cone turning responses.

Kent CB, Shimada T, Ferraro GB, Ritter B, Yam PT, McPherson PS, Charron F, Kennedy TE, Fournier AE.

J Neurosci. 2010 Oct 20;30(42):14059-67. doi: 10.1523/JNEUROSCI.3883-10.2010.

21.

LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition.

Thomas R, Favell K, Morante-Redolat J, Pool M, Kent C, Wright M, Daignault K, Ferraro GB, Montcalm S, Durocher Y, Fournier A, Perez-Tur J, Barker PA.

J Neurosci. 2010 May 12;30(19):6607-12. doi: 10.1523/JNEUROSCI.5147-09.2010.

22.

The atypical protein kinase C in Aplysia can form a protein kinase M by cleavage.

Bougie JK, Lim T, Farah CA, Manjunath V, Nagakura I, Ferraro GB, Sossin WS.

J Neurochem. 2009 May;109(4):1129-43. doi: 10.1111/j.1471-4159.2009.06045.x. Epub 2009 Mar 19.

23.

Refining our understanding of NgR1 function during myelin inhibition.

Ferraro GB.

J Neurosci. 2007 Oct 24;27(43):11451-2. Review. No abstract available.

24.

Neuronal responses to myelin are mediated by rho kinase.

Alabed YZ, Grados-Munro E, Ferraro GB, Hsieh SH, Fournier AE.

J Neurochem. 2006 Mar;96(6):1616-25. Epub 2006 Jan 25.

25.
26.

Molecular targets to promote central nervous system regeneration.

Ferraro GB, Alabed YZ, Fournier AE.

Curr Neurovasc Res. 2004 Jan;1(1):61-75. Review. Erratum in: Curr Neurovasc Res. 2004 Apr;1(2):191.

PMID:
16181067

Supplemental Content

Loading ...
Support Center